AIMNYSEBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
AIM ImmunoTech Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026
$0.16−0.01 (-2.97%)
Close on Oct 19, 2026
- Market cap
- $2.79M
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
3.8%
1M of 30M shares
Institutional holders
18
4 new, 4 sold out
Net institutional buying
1M
In Q2 2026
Insider trades, 12 months
4 buys · 0 sales
Net bought $13.49K
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Orca Capital AG | 1,793,999 | 9.90% | 13G (passive) | May 7, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of AIM | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Jane Street Group, LLC | 807,885 | 2.65% | $229.44K | +787,838 | 0.00% |
| Virtu Financial LLC | 124,269 | 0.41% | $35 | +73,374 | 0.00% |
| Morgan Stanley | 50,864 | 0.17% | $14.45K | +50,000 | 0.00% |
| Geode Capital Management, LLC | 46,003 | 0.15% | $13.06K | +16,085 | 0.00% |
| Goldman Sachs Group Inc | 32,444 | 0.11% | $9.21K | New | 0.00% |
| UBS Group AG | 28,931 | 0.10% | $8.22K | +28,930 | 0.00% |
| Susquehanna International Group, Llp | 21,859 | 0.07% | $6.21K | New | 0.00% |
| Vanguard Fiduciary Trust Co | 17,519 | 0.06% | $4.98K | – | 0.00% |
| Ground Swell Capital, LLC | 12,222 | 0.04% | $3.47K | New | 0.00% |
| Tower Research Capital LLC (TRC) | 4,668 | 0.02% | $1.33K | – | 0.00% |
| Continuum Advisory, LLC | 500 | 0.00% | $142 | New | 0.00% |
| Community Bank, N.A. | 132 | 0.00% | $36 | – | 0.00% |
| Harbour Investments, Inc. | 32 | 0.00% | $9 | – | 0.00% |
| Creative Financial Designs Inc /Adv | 30 | 0.00% | $9 | – | 0.00% |
| Osaic Holdings, Inc. | 15 | 0.00% | $3 | – | 0.00% |
| Hoey Investments, Inc | 10 | 0.00% | $3 | – | 0.00% |
| Intesa Sanpaolo Wealth Management | 1 | 0.00% | $0 | – | 0.00% |
| Farther Finance Advisors, LLC | 1 | 0.00% | $0 | – | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 18 | 1M | 3.8% | 4 / 5 | 0 / 4 | 1M | 0M |
| Q1 2026 | 18 | 0M | 0.6% | 8 / 2 | 1 / 2 | 0M | 0M |
| Q4 2025 | 13 | 0M | 0.3% | 2 / 5 | 0 / 4 | 0M | 0M |
| Q3 2025 | 15 | 0M | 0.4% | 5 / 3 | 1 / 2 | 0M | 0M |
| Q2 2025 | 12 | 0M | 0.0% | 12 / 0 | 0 / 0 | 0M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of AIM | Value | % of fund | As of |
|---|---|---|---|---|---|
| Fidelity Extended Market Index Fund | 27,999 | 0.09% | $11.42K | 0.00% | May 31, 2026 |
| Fidelity Series Total Market Index Fund | 682 | 0.00% | $278 | 0.00% | May 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Thomas K. Equels | CEO & President, Director | 139,822 | 0.46% | Sep 18, 2026 |
| Peter W. Rodino III | COO, Secretary, Gen. Counsel | 401,762 | 1.32% | Apr 4, 2025 |
| David I. Chemerow | Director | 31,882 | 0.10% | Mar 16, 2026 |
| Ted D. Kellner | Director | 2,006,709 | 6.59% | Jul 21, 2025 |
| William M. Mitchell | Director | 522,103 | 1.72% | Apr 23, 2025 |
| Nancy Bryan | Director | 291,882 | 0.96% | Mar 18, 2025 |
| Stewart Appelrouth | Director | 388,729 | 1.28% | Jan 3, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Thomas K. Equels CEO & President, Director | Sep 17, 2026 | Buy | +24,000 | $0.21 | $5.04K | 126,822 |
| Thomas K. Equels CEO & President, Director | Sep 16, 2026 | Buy | +11,000 | $0.21 | $2.31K | 102,822 |
| Thomas K. Equels CEO & President, Director | Sep 15, 2026 | Buy | +22,000 | $0.22 | $4.84K | 91,822 |
| Thomas K. Equels CEO & President, Director | Sep 14, 2026 | Buy | +5,900 | $0.22 | $1.30K | 69,822 |
| Thomas K. Equels CEO & President, Director | Mar 12, 2026 | Conversion | +25,000 | – | – | 63,922 |
| David I. Chemerow Director | Mar 12, 2026 | Conversion | +25,000 | – | – | 28,441 |
| David I. Chemerow Director | Feb 5, 2026 | Award | +2,800 | $1.23 | $3.44K | 3,441 |
| Thomas K. Equels CEO & President, Director | Jun 13, 2025 | Buy | +107 | $7.70 | $824 | 38,885 |
| Thomas K. Equels CEO & President, Director | Jun 12, 2025 | Buy | +103 | $8.70 | $896 | 38,675 |
| Thomas K. Equels CEO & President, Director | Apr 11, 2025 | Buy | +1,968,504 | $0.03 | $59.06K | 3,867,533 |
| William M. Mitchell Director | Apr 11, 2025 | Buy | +196,851 | $0.03 | $5.91K | 521,723 |
| Ted D. Kellner Director | Apr 11, 2025 | Buy | +1,968,504 | $0.03 | $59.06K | 1,969,504 |
| Thomas K. Equels CEO & President, Director | Apr 4, 2025 | Buy | +41,000 | $0.06 | $2.46K | 1,899,029 |
| Peter W. Rodino III COO, Secretary, Gen. Counsel | Apr 4, 2025 | Buy | +500 | $0.09 | $45 | 401,762 |
| Nancy Bryan Director | Mar 14, 2025 | Award | +44,899 | $0.12 | $5.39K | 291,882 |
| David I. Chemerow Director | Mar 14, 2025 | Award | +44,899 | $0.12 | $5.39K | 64,189 |
| William M. Mitchell Director | Mar 14, 2025 | Award | +44,899 | $0.12 | $5.39K | 324,872 |
| Thomas K. Equels CEO & President, Director | Mar 5, 2025 | Buy | +50,000 | $0.13 | $6.50K | 1,858,029 |
| Thomas K. Equels CEO & President, Director | Mar 4, 2025 | Buy | +44,000 | $0.12 | $5.28K | 1,808,029 |
| Thomas K. Equels CEO & President, Director | Mar 4, 2025 | Buy | +83,334 | $0.12 | $10.00K | 1,764,029 |
| David I. Chemerow Director | Feb 28, 2025 | Award | +19,290 | $0.14 | $2.70K | 19,290 |
| William M. Mitchell Director | Feb 28, 2025 | Award | +38,580 | $0.14 | $5.40K | 279,973 |
| Nancy Bryan Director | Feb 28, 2025 | Award | +38,580 | $0.14 | $5.40K | 246,983 |
| William M. Mitchell Director | Feb 14, 2025 | Award | +43,330 | $0.12 | $5.20K | 241,393 |
| William M. Mitchell Director | Feb 14, 2025 | Award | −43,330 | $0.12 | $5.20K | 241,393 |
| Nancy Bryan Director | Feb 14, 2025 | Award | +43,330 | $0.12 | $5.20K | 208,403 |
| William M. Mitchell Director | Jan 31, 2025 | Award | +25,797 | $0.20 | $5.16K | 198,063 |
| William M. Mitchell Director | Jan 31, 2025 | Award | −25,797 | $0.20 | $5.16K | 198,063 |
| Nancy Bryan Director | Jan 31, 2025 | Award | +25,797 | $0.20 | $5.16K | 165,073 |
| William M. Mitchell Director | Jan 15, 2025 | Award | +27,412 | $0.19 | $5.21K | 172,266 |
| William M. Mitchell Director | Jan 15, 2025 | Award | −27,412 | $0.19 | $5.21K | 172,226 |
| Nancy Bryan Director | Jan 15, 2025 | Award | +27,412 | $0.19 | $5.21K | 139,276 |
| Nancy Bryan Director | Dec 31, 2024 | Award | +26,305 | $0.20 | $5.26K | 111,864 |
| William M. Mitchell Director | Dec 31, 2024 | Award | +26,305 | $0.20 | $5.26K | 144,854 |
| Stewart Appelrouth Director | Dec 31, 2024 | Award | +8,768 | $0.20 | $1.75K | 388,729 |
| William M. Mitchell Director | Dec 19, 2024 | Sale | −4,580 | $0.19 | $870 | 118,549 |
| Thomas K. Equels CEO & President, Director | Dec 18, 2024 | Buy | +22,727 | $0.21 | $4.77K | 1,680,695 |
| William M. Mitchell Director | Dec 13, 2024 | Award | +24,452 | $0.21 | $5.13K | 123,803 |
| Nancy Bryan Director | Dec 13, 2024 | Award | +24,452 | $0.21 | $5.13K | 85,559 |
| Stewart Appelrouth Director | Dec 13, 2024 | Award | +24,452 | $0.21 | $5.13K | 379,961 |
| Stewart Appelrouth Director | Dec 2, 2024 | Buy | +11,111 | $0.21 | $2.33K | 355,509 |
| Stewart Appelrouth Director | Dec 2, 2024 | Buy | +1 | $0.21 | $0 | 344,398 |
| Nancy Bryan Director | Dec 2, 2024 | Award | +22,645 | $0.23 | $5.21K | 61,107 |
| Stewart Appelrouth Director | Dec 2, 2024 | Award | +22,645 | $0.23 | $5.21K | 344,397 |
| William M. Mitchell Director | Dec 2, 2024 | Award | +22,645 | $0.23 | $5.21K | 99,351 |
| Thomas K. Equels CEO & President, Director | Nov 21, 2024 | Buy | +20,000 | $0.21 | $4.20K | 1,657,968 |
| Thomas K. Equels CEO & President, Director | Nov 20, 2024 | Buy | +85,000 | $0.20 | $17.00K | 1,637,968 |
| Stewart Appelrouth Director | Nov 20, 2024 | Buy | +81,953 | $0.19 | $15.57K | 321,752 |
| Thomas K. Equels CEO & President, Director | Nov 20, 2024 | Buy | +60,110 | $0.18 | $10.82K | 1,552,968 |
| Thomas K. Equels CEO & President, Director | Sep 16, 2024 | Buy | +5,000 | $0.30 | $1.50K | 1,493,042 |
| Thomas K. Equels CEO & President, Director | Sep 13, 2024 | Buy | +20,000 | $0.31 | $6.20K | 1,488,042 |
| Thomas K. Equels CEO & President, Director | Sep 11, 2024 | Award | +312,500 | $0.32 | $100.00K | 1,468,042 |
| Thomas K. Equels CEO & President, Director | Aug 12, 2024 | Award | +377,358 | $0.27 | $101.89K | 1,155,542 |
| Peter W. Rodino III COO, Secretary, Gen. Counsel | Aug 12, 2024 | Award | +188,679 | $0.27 | $50.94K | 401,262 |
| Peter W. Rodino III COO, Secretary, Gen. Counsel | May 6, 2024 | Buy | +30,865 | $0.41 | $12.65K | 212,583 |
| Thomas K. Equels CEO & President, Director | May 6, 2024 | Buy | +61,729 | $0.41 | $25.31K | 778,184 |
| Nancy Bryan Director | Mar 21, 2024 | Buy | +38,462 | $0.39 | $15.00K | 38,462 |
| Stewart Appelrouth Director | Mar 15, 2024 | Buy | +90,910 | $0.33 | $30.00K | 239,765 |
| Peter W. Rodino III COO, Secretary, Gen. Counsel | Mar 15, 2024 | Buy | +37,879 | $0.33 | $12.50K | 181,718 |
| Thomas K. Equels CEO & President, Director | Mar 15, 2024 | Buy | +75,758 | $0.33 | $25.00K | 716,455 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.